Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.
about
Hypomyelination and increased activity of voltage-gated K(+) channels in mice lacking protein tyrosine phosphatase epsilonConsequences of irradiation on bone and marrow phenotypes, and its relation to disruption of hematopoietic precursors2-(oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatasesThe transmembranal and cytoplasmic forms of protein tyrosine phosphatase epsilon physically associate with the adaptor molecule Grb2Bisphosphonates: from bench to bedsideBAR Proteins PSTPIP1/2 Regulate Podosome Dynamics and the Resorption Activity of OsteoclastsThe pharmacology of bisphosphonates and new insights into their mechanisms of action.Osteoblastic protein tyrosine phosphatases inhibition and connexin 43 phosphorylation by alendronate.How do bisphosphonates inhibit bone metastasis in vivo?Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo.Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders.Bisphosphonates in bone cement inhibit PMMA particle induced bone resorptionModulation of osteoclastogenesis induced by nucleoside reverse transcriptase inhibitors.Targeting the PTPome in human disease.Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survival.Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.Role of protein-tyrosine phosphatases in regulation of osteoclastic activity.Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary studyImplant failure caused by non-union of bisphosphonate-associated subtrochanteric femur fracture.Bisphosphonates and atypical subtrochanteric fractures of the femur.Aminobisphosphonates Synergize with Human Cytomegalovirus To Activate the Antiviral Activity of Vγ9Vδ2 Cells.Bisphosphonates: mechanisms of action.The inhibitory effect of alendronate, a nitrogen-containing bisphosphonate on the PI3K-Akt-NFkappaB pathway in osteosarcoma cells.MMP inhibition and downregulation by bisphosphonates.Is all bone the same? Distinctive distributions and properties of non-collagenous matrix proteins in lamellar vs. woven bone imply the existence of different underlying osteogenic mechanisms.Effect of a newly developed bisphosphonate, YH529, on osteolytic bone metastases in nude mice.Inhibition of inflammatory actions of aminobisphosphonates by dichloromethylene bisphosphonate, a non-aminobisphosphonate.Effects of topical administration of clodronate on alveolar bone resorption in rats with experimental periodontitis.Expression of a structurally unique osteoclastic protein-tyrosine phosphatase is driven by an alternative intronic, cell type-specific promoter.Bisphosphonates stimulate an endogenous nonselective cation channel in Xenopus oocytes: potential mechanism of action.Violacein cytotoxicity on human blood lymphocytes and effect on phosphatases.Histochemical evidence of zoledronate inhibiting c-src expression and interfering with CD44/OPN-mediated osteoclast adhesion in the tibiae of mice.Influence of Feeding Inorganic Vanadium on Growth Performance, Endocrine Variables and Biomarkers of Bone Health in Crossbred Calves.
P2860
Q24630874-78498CA6-B991-4DCD-A63B-811ADC514BCEQ26864483-1C41DB11-574A-43A0-A62B-CD7D1C5CD61FQ27621646-60B7353C-47B5-462D-A767-3ADBC88BF3EEQ28144584-61B80364-14CF-4C23-8142-D48216BD15D2Q28251212-02C022AB-21CB-409D-974C-145F6EF254AAQ30008840-1F339171-09F3-453E-9D4A-58216127E4B5Q33746152-9DE348C7-DD38-4324-88D1-B632A6AB3A93Q33827663-5EA68C8D-C4FC-4B4C-AD83-713E657D8701Q34009853-C2DFCAB0-5F43-4990-9D60-DFE1D1A4CCA8Q34786247-5F7E9152-8215-4584-83EF-EAC67DA3B657Q34793691-A21B3BF9-8461-420D-9958-84CE0D24F8E1Q35000983-F98C7FA8-093A-44F1-878D-0BD35FF161F1Q35547563-FD159617-38CB-4F74-BE43-70BCD2D050FEQ36013609-E08BDFB2-919D-4D9A-A95B-5353C600FCD6Q36379394-0EE5840F-44F3-49FD-81E0-6CB881304F31Q36670757-B8068519-7581-49E8-ABEF-1B59FA099142Q36695888-D3D81B77-B3B0-4569-AD15-37500B4915BDQ37263070-BEAD0A98-FE93-419F-9BEA-67FD33A71A61Q37411072-7D09ACDD-A5F5-4D13-BBFF-C82F7F191232Q37704201-AC10E452-7D0C-47E1-993C-75C048C559B4Q37733851-D2EA8516-EAD5-423E-BC25-D4B8637A0199Q38798990-FE7E8853-A439-4DFC-8A91-E72EC934F518Q39766013-906763CE-1EF5-4FE2-954C-F9BD49C40C90Q40385248-6320C26F-A2AA-4CF0-B914-5B18471511F5Q40804689-B38F4848-A3ED-4422-BED9-042942197652Q40857866-DD0A224F-F7F8-4A01-A5AC-6F36B38FE9EFQ41028782-0F523796-29F4-49E2-8ADF-94B846E9E2D2Q42172781-E916057F-604D-4679-81AB-DC93D72123F4Q44003832-2AEE2601-D307-46F7-9D09-B234A30791FDQ44569156-3AC52729-E251-4BAD-A811-2A661D6F8F87Q46402357-BC68E86A-C789-405F-AAEA-4BE3218DC1A2Q46840654-C24666F4-F3E8-46C8-A429-B5D5737777A4Q47705796-56F0A613-13E1-47F3-826E-2AED98FFBF85Q48361524-4ECC790D-AAE1-42F4-A4EC-AA677B89CD13
P2860
Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protein-tyrosine phosphatase a ...... on: inhibition by alendronate.
@en
Protein-tyrosine phosphatase a ...... on: inhibition by alendronate.
@nl
type
label
Protein-tyrosine phosphatase a ...... on: inhibition by alendronate.
@en
Protein-tyrosine phosphatase a ...... on: inhibition by alendronate.
@nl
prefLabel
Protein-tyrosine phosphatase a ...... on: inhibition by alendronate.
@en
Protein-tyrosine phosphatase a ...... on: inhibition by alendronate.
@nl
P2093
P2860
P356
P1476
Protein-tyrosine phosphatase a ...... on: inhibition by alendronate.
@en
P2093
Ramachandaran C
Rutledge SJ
P2860
P304
P356
10.1073/PNAS.93.7.3068
P407
P577
1996-04-01T00:00:00Z